ClinicalTrials.gov
public full text
Public Domain
Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers
Gastric cancer (GC) is a leading cause of cancer-related death worldwide. Even in patients undergoing curative surgery for non-metastatic disease, postoperative recurrence frequently occurs due to undetected minimal residual disease (MRD). This study aims to establish a highly sensitive and specific liquid biopsy assay using exosomal microRNAs (exo-miRNAs) to detect MRD and predict distant metastasis before clinical recurrence.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- GutCore: An Endoscopy Foundation Model for Whole-Case Gastric Cancer Analysis#459880
- Early detection and subtyping of gastric cancer: A cell-free DNA fragmentome-based liquid biopsy method.#170651
- A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients#894821
- Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer#872470
- Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer#894661
Record · ID 811382
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive